Ultrathin Endoscopy Without Sedation: Is This the Future of Esophagology?

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2342-2344

  Devault, Kenneth R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; COST EFFECTIVENESS ANALYSIS; DRUG MEGADOSE; EDITORIAL; ENDOSCOPY; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HUMAN; PRIORITY JOURNAL; SEDATION;

EID: 0344065105     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjgastroenterol.2003.08.004     Document Type: Editorial

References (17)

1. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999;94:1434-42.
2. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnositic tool in gastroesophageal reflux disease. Am J Gastroentol 1997;92:1997-2000.
3. Schindlbeck NE, Klauser AG, Voderholzer WA, et al. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995;1555:1808-12.
4. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
5. Fass R, Ofman JJ. Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901-9.
6. Weinstein WM. Erosive esophagitis impairs accurate detection of Barrett's esophagus: A prospective randomized double blind study. Gastroenterology 1999;116:A352 (abstract).
7. Wiklund I, Glise H, Jerndal P, et al. Dose endoscopy have a positive impact on quality of life in dyspepsia? Gastrointest Endosc 1998;47:449-54.
8. Sampliner RE. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
9. Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: A systematic review. Scand J Gastroenterol 1999;231(suppl):3-8.
10. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;132:461-7.
11. Ward EM, DeVault KR, Wolfsen HC, et al. Barrett's esophagus in unscreened, older patients undergoing screening or follow-up colonoscopy. Gastroenterology 2003;124(suppl 1): A642.
12. Mokhashi MS, Wildi SM, Glenn TF, et al. A prospective, blinded study of diagnostic esophagoscopy with a superthin, stand-alone, battery-powered endoscope. Am J Gastroenterol 2003;98:2383-9.
13. Catanzaro A, Faulx A, Pfau PR, et al. Accuracy of a narrow-diameter battery-powered endoscope in sedated and unsedated patients. Gastrointest Endosc 2002;55:620-3.
14. Venables TL, Newland RD, Patel AC, et al. Omprazole 10mg once daily, omeprazole 20mg once daily or ranitidine 150mg twice daily, evaluated as initial therapy for the relief of symptoms of gastroesophageal reflux in general practice. Scand J Gastroenterol 1997;32:965-73.
15. Sampliner R, Rarewal H, Fennerty MB, et al. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
16. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995;333:1106-10.
17. Faulx AL, Catanzaro A, Zyzanski S, et al. Patient tolerance and acceptance of unsedated ultrathin esophagoscopy. Gastrointest Endosc 2002;55:620-3.